D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 86,900
-2,700 (-3.01%)
Jun 10, 2026, 3:30 PM KST
D&D Pharmatech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23,200 | -23,555 | -28,623 | 3,934 | -136,067 | -68,224 |
Depreciation & Amortization | 5,514 | 5,531 | 5,527 | 4,428 | 13,739 | 11,901 |
Loss (Gain) From Sale of Assets | 22.04 | 0.13 | 118.38 | 84.78 | -21,524 | - |
Asset Writedown & Restructuring Costs | - | - | 9,199 | -4,582 | 119,722 | - |
Loss (Gain) on Equity Investments | 5,045 | 4,815 | -1,839 | 1,787 | 9,148 | - |
Stock-Based Compensation | 2,312 | 1,472 | 762.94 | 2,843 | 4,057 | 5,576 |
Other Operating Activities | -12,220 | -11,327 | -1,510 | -15,025 | -39,488 | -7,399 |
Change in Accounts Receivable | 251.25 | 3,985 | -3,921 | -3,618 | -231.5 | 897.49 |
Change in Other Net Operating Assets | -2,622 | -2,061 | -1,519 | 1,030 | -2,439 | 5,304 |
Operating Cash Flow | -24,899 | -21,139 | -21,805 | -9,117 | -53,083 | -51,945 |
Capital Expenditures | -36.59 | -64.41 | -395.75 | -45.22 | -711.88 | -1,615 |
Sale of Property, Plant & Equipment | - | - | 8.87 | 323.21 | 240.02 | - |
Sale (Purchase) of Intangibles | - | - | -20 | - | -7.03 | -603.83 |
Other Investing Activities | -42.59 | -25.84 | -132.64 | -9.84 | - | 263.02 |
Investing Cash Flow | -79.18 | -90.25 | -539.53 | 268.14 | -478.89 | -1,955 |
Long-Term Debt Issued | - | - | - | 1,000 | 3,217 | 6,329 |
Total Debt Issued | - | - | - | 1,000 | 3,217 | 6,329 |
Short-Term Debt Repaid | - | -925.12 | - | - | - | - |
Long-Term Debt Repaid | - | -1,843 | -1,730 | -1,625 | -1,378 | -774.99 |
Total Debt Repaid | -1,880 | -2,769 | -1,730 | -1,625 | -1,378 | -774.99 |
Net Debt Issued (Repaid) | -1,880 | -2,769 | -1,730 | -625.25 | 1,839 | 5,554 |
Issuance of Common Stock | 6,137 | 7,382 | 37,980 | - | 147 | 3,014 |
Other Financing Activities | 19,581 | 19,581 | -0 | -4.67 | -0 | -0 |
Financing Cash Flow | 23,838 | 24,195 | 36,251 | -629.92 | 1,986 | 67,692 |
Foreign Exchange Rate Adjustments | -433.3 | -95.36 | 465.06 | -382.5 | 1,123 | 1,554 |
Net Cash Flow | -1,574 | 2,870 | 14,372 | -9,862 | -50,454 | 15,346 |
Free Cash Flow | -24,935 | -21,203 | -22,201 | -9,163 | -53,795 | -53,560 |
Free Cash Flow Margin | -827.62% | -493.38% | -194.12% | -49.06% | -8810.69% | -3926.36% |
Free Cash Flow Per Share | -575.41 | -482.64 | -547.60 | -244.19 | -1668.57 | -1627.16 |
Cash Interest Paid | 374.34 | 396.9 | 400.26 | 454.26 | 510.72 | 247.05 |
Cash Income Tax Paid | - | -22.74 | 55.4 | 1,896 | 83.39 | 354.64 |
Levered Free Cash Flow | -32,457 | -27,099 | -13,079 | -28,427 | -29,052 | -14,039 |
Unlevered Free Cash Flow | -32,207 | -26,805 | -12,695 | -27,535 | -27,203 | -13,407 |
Change in Working Capital | -2,371 | 1,925 | -5,440 | -2,587 | -2,670 | 6,201 |